EPAS1 and neoplasm: In spite of that, Mazumdar et al. (2010) [22], employing a KRAS-driven lung tumour model, demonstrated that HIF1α deletion presents a very small effect on tumour weight and progression, whereas the loss of HIF2α actually increased tumour growth and progression.